1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Demographic characteristics^{^a}
Group A (1 mL) (n = 139) Group B (2 mL) (n = 169) Group C (3 mL) (n = 154) P Value
Age (yr) 60.3 ± 13.6 62.2 ± 13.4 63.2 ± 14.5 .184
Male/female 80:59 94:75 83:71 .821
Body weight (kg) 63.4 ± 11.6 63.9 ± 10.3 62.4 ± 10.1 .498
Contrast dose of CE-MRA (mL) 6.3 ± 1.2 6.4 ± 1.0 6.2 ± 1.0 .498
Time between CE-MRA and TR-MRA (sec) 224 ± 21 251 ± 42 233 ± 36 .532
↵a Data are means.

	Group A (1 mL) (n = 139)	Group B (2 mL) (n = 169)	Group C (3 mL) (n = 154)	P Value
Age (yr)	60.3 ± 13.6	62.2 ± 13.4	63.2 ± 14.5	.184
Male/female	80:59	94:75	83:71	.821
Body weight (kg)	63.4 ± 11.6	63.9 ± 10.3	62.4 ± 10.1	.498
Contrast dose of CE-MRA (mL)	6.3 ± 1.2	6.4 ± 1.0	6.2 ± 1.0	.498
Time between CE-MRA and TR-MRA (sec)	224 ± 21	251 ± 42	233 ± 36	.532